Stephanie Plaines - 31 Dec 2025 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Jinho Joo, Attorney-in-Fact
Issuer symbol
CLX
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 16:47:53 UTC
Previous filing
02 Oct 2025
Next filing
23 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Plaines Stephanie Director 1221 BROADWAY, OAKLAND By Jinho Joo, Attorney-in-Fact 05 Jan 2026 0001771330

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +63 +1.2% $0.000000 5,476 06 Nov 2025 Common Stock 63 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1,638 +30% $0.000000 7,114 31 Dec 2025 Common Stock 1,638 Direct F1, F3, F4
transaction CLX Deferred Stock Units Award $0 +273 +3.8% $0.000000 7,387 31 Dec 2025 Common Stock 273 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.